Serine Peptidase Inhibitor Kazal Type 5 (SPINK5)
[Edit]LEKTI; LETKI; NETS; NS; VAKTI; Lymphoepithelial Kazal-Type-Related Inhibitor; Lympho-epithelial Kazal-type-related inhibitor
SPINK5 encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The inhibitor may play a role in skin and hair morphogenesis and anti-inflammatory and/or antimicrobial protection of mucous epithelia. Mutations may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy.The entire precursor protein, as deduced from the nucleotide sequence of the cloned cDNA, includes 15 potential inhibitory domains, 13 of which exhibit a Kazal-type-derived 4-cysteine-residue pattern that represents a novel protein module of serine protease inhibitor. Northern blot analysis and RT-PCR detected expression of LEKTI in thymus, vaginal epithelium, Bartholin gland, oral mucosa, tonsil, and parathyroid gland.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | RPH145Hu01 | Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Positive Control; Immunogen; SDS-PAGE; WB. |
Antibodies | PAH145Hu01 | Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | WB; IHC; ICC; IP. |
MAH145Hu21 | Monoclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | WB | |
LAH145Hu71 | Biotin-Linked Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | WB; IHC; ICC. | |
Assay Kits | SEH145Hu | ELISA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Enzyme-linked immunosorbent assay for Antigen Detection. |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | RPH145Mu01 | Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPH145Mu02 | Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Positive Control; Immunogen; SDS-PAGE; WB. | |
Antibodies | PAH145Mu01 | Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | WB; IHC; ICC; IP. |
PAH145Mu02 | Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | WB; IHC; ICC; IP. | |
Assay Kits | SEH145Mu | ELISA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Enzyme-linked immunosorbent assay for Antigen Detection. |
Organism species: Rattus norvegicus (Rat)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Serine Peptidase Inhibitor Kazal Type 5 (SPINK5) | ELISA Kit Customized Service Offer |
- "LEKTI, a novel 15-domain type of human serine proteinase inhibitor."J. Biol. Chem. 274:21499-21502(1999) [PubMed] [Europe PMC] [Abstract]
- "Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome."Nat. Genet. 25:141-142(2000) [PubMed] [Europe PMC] [Abstract]
- "SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing."J. Invest. Dermatol. 126:315-324(2006) [PubMed] [Europe PMC] [Abstract]
- "The DNA sequence and comparative analysis of human chromosome 5." Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract]
- "The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis."J. Invest. Dermatol. 117:179-187(2001) [PubMed] [Europe PMC] [Abstract]
- "Purification and partial amino acid sequence of proteins from human epidermal keratinocyte conditioned medium."J. Protein Chem. 20:273-278(2001) [PubMed] [Europe PMC] [Abstract]
- "LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction."Mol. Biol. Cell 18:3607-3619(2007) [PubMed] [Europe PMC] [Abstract]
- "New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI."J. Proteome Res. 9:4289-4294(2010) [PubMed] [Europe PMC] [Abstract]
- "Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI."J. Mol. Biol. 328:205-219(2003) [PubMed] [Europe PMC] [Abstract]
- "The solution structure of a chimeric LEKTI domain reveals a chameleon sequence."Biochemistry 43:11238-11247(2004) [PubMed] [Europe PMC] [Abstract]
- "Gene polymorphism in Netherton and common atopic disease."Nat. Genet. 29:175-178(2001) [PubMed] [Europe PMC] [Abstract]